90 related articles for article (PubMed ID: 26718430)
1. Investigation of some DNA repair genes association in non small cell lung cancer.
Coskunpinar E; Yildiz P; Aynaci E; Turna A; Musteri Oltulu Y; Hekimoglu E; Isbir T; Yaylim I
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):57-62. PubMed ID: 26718430
[TBL] [Abstract][Full Text] [Related]
2. RRM1, RRM2 and ERCC2 Gene Polymorphisms in Coronary Artery Disease.
Altinkilic EM; Isbir S; Gormus U; Yilmaz SG; Dalan AB; Duman S; Isbir T
In Vivo; 2016 09-10; 30(5):611-5. PubMed ID: 27566080
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of BRCA1, ERCC1, RRM1, and RRM2 in patients with advanced non-small cell lung cancer receiving chemotherapy.
Zhao H; Zhang H; Du Y; Gu X
Tumour Biol; 2014 Dec; 35(12):12679-88. PubMed ID: 25227663
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
5. The genotype of ribonucleotidereductase M1 -269C > A is associated with the response to platinum-based chemotherapy and as a prognostic biomarker in advanced nonsmall cell lung cancer.
Xu XL; Zhang YP; Fang Y; Su D; Chen W; Feng JG; Li ZP; Mao WM
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C49-55. PubMed ID: 26323924
[TBL] [Abstract][Full Text] [Related]
6. Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer.
Chen DR; Chuang CY; Wu BC; Yang SF; Peng YH; Tsai HT
J Clin Lab Anal; 2014 Jul; 28(4):287-93. PubMed ID: 24578158
[TBL] [Abstract][Full Text] [Related]
7. RRM1 *151A>T, RRM1 -756T>C, and RRM1 -585T>Gis associated with increased susceptibility of lung cancer in Chinese patients.
Xu XL; Zheng J; Mao WM; Ling ZQ
Cancer Med; 2016 Aug; 5(8):2084-90. PubMed ID: 27335251
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
[TBL] [Abstract][Full Text] [Related]
9. Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.
Liao WY; Ho CC; Tsai TH; Chen KY; Shih JY; Yu CJ
Lung Cancer; 2018 Apr; 118():90-96. PubMed ID: 29572009
[TBL] [Abstract][Full Text] [Related]
10. DNA Repair Gene Polymorphisms in Relation to Non-Small Cell Lung Cancer Survival.
Su Y; Zhang H; Xu F; Kong J; Yu H; Qian B
Cell Physiol Biochem; 2015; 36(4):1419-29. PubMed ID: 26159902
[TBL] [Abstract][Full Text] [Related]
11. RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer.
Bepler G; Sharma S; Cantor A; Gautam A; Haura E; Simon G; Sharma A; Sommers E; Robinson L
J Clin Oncol; 2004 May; 22(10):1878-85. PubMed ID: 15143080
[TBL] [Abstract][Full Text] [Related]
12. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
[TBL] [Abstract][Full Text] [Related]
13. Association of ERCC2 Gene Polymorphisms with Susceptibility to Diffuse Large B-Cell Lymphoma.
Tong Y; Xiang Y; Li B; Bao S; Zhou Y; Yuan W; Ling Y; Hao D; Zhu H; Sun Z
Med Sci Monit; 2018 Oct; 24():7015-7022. PubMed ID: 30279407
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer.
Kim M; Kang HG; Lee SY; Lee HC; Lee EB; Choi YY; Lee WK; Cho S; Jin G; Jheon HS; Son JW; Lee MH; Jung DK; Cha SI; Kim CH; Kang YM; Kam S; Jung TH; Jheon S; Park JY
Cancer Sci; 2010 Nov; 101(11):2436-42. PubMed ID: 20731661
[TBL] [Abstract][Full Text] [Related]
15. Allele and Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Lung Cancer in ther Jordanian Population: a Case Control Study.
Al-Motassem Y; Shomaf M; Said I; Berger S; Ababneh N; Diab O; Obeidat N; Awidi A
Asian Pac J Cancer Prev; 2015; 16(8):3101-9. PubMed ID: 25921104
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India.
Srivastava K; Srivastava A; Mittal B
Cancer; 2010 Jul; 116(13):3160-9. PubMed ID: 20564624
[TBL] [Abstract][Full Text] [Related]
17. Association of the Genetic Polymorphisms RRM1 -756T>C and -269C>A With Cervical Neoplasia.
Chang CW; Yang SF; Wang PH; Chang HJ; Liu WC; Tsai HT
Biol Res Nurs; 2016 Oct; 18(5):567-72. PubMed ID: 27179014
[TBL] [Abstract][Full Text] [Related]
18. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
19. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
[TBL] [Abstract][Full Text] [Related]
20. Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance.
Bepler G; Zheng Z; Gautam A; Sharma S; Cantor A; Sharma A; Cress WD; Kim YC; Rosell R; McBride C; Robinson L; Sommers E; Haura E
Lung Cancer; 2005 Feb; 47(2):183-92. PubMed ID: 15639717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
